Cfr.org14d
American Pharmaceutical Companies Still Aren’t Paying Tax in the U.S.
Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...
Newswire21d
Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited
HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...
esmmagazine.com21d
Boots Parent Walgreens To Be Taken Private By Sycamore
Walgreens Boots Alliance will be taken private by Sycamore Partners for $10 billion (€9.2 billion), the firms said, closing out nearly a century of trading on public markets for the US pharmacy ...
Business Insider26d
Zealand Pharma removed from European Conviction List at Goldman Sachs
Goldman Sachs analysts removed Zealand Pharma (ZLDPF) from the firm’s European Conviction List as part of its monthly update. See what stocks are receiving Strong Buy ratings from top-rated ...
Yahoo Finance29d
Is Walgreens Boots Alliance, Inc. (WBA) the Best Low Price Pharma Stock to Invest In Right Now?
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Walgreens Boots Alliance, Inc. (NASDAQ:WBA ...
Business Insider1mon
Verona Pharma (VRNA) Receives a Buy from Roth MKM
Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $68.00. The company’s shares closed last Friday at $67.96.
PR Newswire1mon
Innocan Pharma Granted First Patent in India for its Liposomal CBD Injection
HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a ...
Longview News-Journal1mon
Aurora Pharmaceutical Delivers on FDA-Approved Generic for Equine Pain Relief
NORTHFIELD, Minn., Feb. 13, 2025 /PRNewswire/ -- Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx ® (firocoxib), a non ...
WROC-TV1mon
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, SKYTROFA®, and YORVIPATH® are trademarks owned by the Ascendis Pharma group.
PR Newswire1mon
Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone
HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a ...
News Medical6mon
Continuous vs. Batch Manufacturing: What's the Difference?
Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch ...